Siemens Healthcare Chooses Cologne As The New Site For Its Molecular Diagnostics Research In Germany

 05.06.2008 17:14   medicalnewstoday.com

Siemens Healthcare has established new research laboratories for molecular diagnostics in Cologne, Germany. The focus of the research will be on "breast cancer", a disease that remains the number one cause of death among young women despite the large number of therapies currently available.

World Cancer